English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Data Source We evaluated the Cochrane systematic review of randomised controlled trials [1]. Trials were identified by searching Medline, Embase, Central Cochrane Library, Cochrane Dementia and Cognitive Improvement Group database, abstract from proceedings of the main Dementia Conferences, and by contacting the pharmaceutical company, Novartis, for unpublished and published trials. The search was updated to December 2000.

Does Rivastigmine Improve Cognitive Functions or Disability in Patients with Alzheimer’s Disease?